Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
PR Newswire•23/09/2026•09:20 ET
0
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany PR Newswire
MINNEAPOLIS, Sept. 23, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive agreement under which Merck KGaA, Darmstadt, Germany proposes to acquire Bio-Techne (the "Merger Agreement") at a Special Meeting of Shareholders held today.
Get started
Create a free account to read the full story and Whiz Insights.